Lebrikizumab Improves Lung Function in Asthma – Medscape

Lebrikizumab Improves Lung Function in Asthma
Medscape
August 4, 2011 — Treatment with the anti-interleukin-13 antibody lebrikizumab was associated with a significant improvement in lung function at week 12 compared to baseline in patients with poorly controlled asthma, according to the findings of a
Researchers find potential new treatment for asthma sufferersBCM News
Lebrikizumab Ups Lung Function in Adults With AsthmaDoctors Lounge
IL-13 Blocker Helps Asthma ControlMedPage Today
U.S. News & World Report –Fox Business –Reuters
all 22 news articles »

View full post on asthma – Google News

Lebrikizumab Ups Lung Function in Adults With Asthma – Doctors Lounge

Lebrikizumab Ups Lung Function in Adults With Asthma
Doctors Lounge
Treatment with lebrikizumab increases lung function in adults with asthma, especially for those with high levels of serum periostin, according to a study published online Aug. 3 in the New England Journal of Medicine. THURSDAY, Aug.
IL-13 Blocker Helps Asthma ControlMedPage Today
Experimental Drug Promising Against Tough-to-Treat AsthmaU.S. News & World Report
Roche Asthma Drug Meets Primary Endpoint In Phase II StudyFox Business
Reuters –FierceBiotech –InPharm
all 18 news articles »

View full post on asthma – Google News